Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors

Robust and accurate quantification of recombinant adeno-associated virus (rAAV) vectors’ infectivity is essential for pre-clinical and clinical development of AAV gene therapy programs. The industry standard method for rAAV titration is the 50% tissue culture infectious dose (TCID50) assay using HeL...

Descripción completa

Detalles Bibliográficos

Autores principales:	Chloé Fustinoni, Xiang Liu, Zhi Chen, Ryan Cawood, Weimin Valenti, Maria I. Patrício, Weiheng Su
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2025-06-01
Colección:	Molecular Therapy: Methods & Clinical Development
Materias:	rAAV infectious titer TCID50 TESSA TREAT assay
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2329050125000877
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!